Cargando…
Association of metformin exposure with low risks of frailty and adverse outcomes in patients with diabetes
BACKGROUND: Diabetes is an independent risk factor of frailty, which increases adverse outcomes in patients with diabetes. Metformin is a common antidiabetic drug in clinical practice. Insulin resistance and chronic inflammation are the two common mechanisms of diabetes and frailty, as well as the m...
Autores principales: | Liu, Pan, Pan, Yiming, Song, Yu, Zhou, Yaru, Zhang, Wanshu, Li, Xiaojun, Li, Jiatong, Li, Yun, Ma, Lina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896807/ https://www.ncbi.nlm.nih.gov/pubmed/36732827 http://dx.doi.org/10.1186/s40001-023-01017-6 |
Ejemplares similares
-
Metabolomics-Based Biomarkers for Frailty in Chinese Older Adults
por: Pan, Yiming, et al.
Publicado: (2021) -
Visceral Fat Obesity Correlates with Frailty in Middle-Aged and Older Adults
por: Li, Bixi, et al.
Publicado: (2022) -
Is There an Association Between Metformin Exposure and Frailty?
por: Baskaran, Dhanya, et al.
Publicado: (2020) -
Caloric Restriction May Help Delay the Onset of Frailty and Support Frailty Management
por: Liu, Pan, et al.
Publicado: (2021) -
Metabolomics-Based Frailty Biomarkers in Older Chinese Adults
por: Pan, Yiming, et al.
Publicado: (2022)